Are We Missing a Critical Window for Preventing Diarrheal Deaths in Children?

By Kate Pfizenmaier / Global WACh

Death from diarrheal disease is entirely preventable yet it remains the second leading cause of death worldwide in children under five. When a child arrives at a clinic with severe diarrhea in a low-income country, say Kenya, what dictates the treatment they get? How do we define the severity of their condition and when do we assume it could be life threatening? 

Washington State Should Pass Parental Leave

By Kyleen Luhrs, Alee Perkins, Rachel Shaffer, Kelsey Sholund, Manahil Siddiqi, and Rebecca Wu, students at the University of Washington schools of medicine and public health. Manahil Siddiqi is pursuing a graduate certificate in the global health of women, adolescents and children.

As students at the University of Washington School of Medicine and School of Public Health, we are concerned about the lack of paid parental leave in Washington state.

Teaching Children with Cerebral Palsy to Walk: UW Exoskeleton Project Wins $30,000 to Develop New Technology

Imagine a therapeutic device that children with cerebral palsy could wear at home to strengthen their legs and increase their mobility, eventually allowing them to walk without assistance.  Now imagine the device was low-tech and affordable, making it accessible to children around the globe who have limited or no access to expensive therapies that require robotics, supervision by a trained clinician, or invasive surgeries.

Global WACh Announces New Scientific Priorities

The Global Center for Woman, Adolescent, and Child health completed its fifth year in June 2016. A Center within the Department of Global Health, it was established to pursue scientific discovery and leadership development by breaking down traditional silos that separate disciplines. Their approach to research was framed from a lifecycle perspective -- one that views women, children and adolescents as interconnected populations that move along a shared life course.

In February Global WACh introduced three newly articulated scientific priority areas:

SPH: Targeted Testing for Children of HIV-Infected Adults

By the School of Public Health

Testing the children of HIV-infected adults already receiving care may efficiently diagnose HIV-infected children before they exhibit symptoms, according to researchers from the University of Washington School of Public Health.

By referring HIV-infected parents to have their children tested, researchers revealed many untested older children and found that prevalence of HIV was high. This new active referral model significantly increased the rate of pediatric testing with limited additional costs to health systems.

Focusing on Adolescents For an AIDS-Free Generation

Op-ed by Jennifer Slyker

This World AIDS Day, we applaud gains against the world HIV/AIDS epidemic and optimistically embark upon a new vaccine trial. But we also recognize our work is far from done especially when it comes to young people. Without a significant global transformation in priorities and resources towards adolescents, we leave them at risk of dying from a preventable and treatable disease.

Department Part of Major Study to Test Antibiotics as a Treatment for Diarrheal Disease in High-Risk Children in Low Resource Settings

By Amelia Vader

Researchers at the University of Washington and Kenya Medical Research Institute are working to determine if antibiotics could help save thousands of children from dying of diarrheal disease thanks to a four-year $2.5 million grant from the World Health Organization.

The Antibiotics for Children with Severe Diarrhea (ABCD) Trial is the largest clinical trial addressing diarrhea management to date; and it will not only answer the question of the potential benefits of antibiotics it will also address any potential harm, such as antibiotic resistance.

UW Awarded DREAMS Innovation Challenge to Bring PrEP to Adolescents in Kenya

The University of Washington is one of 56 DREAMS Innovation Challenge winners* announced on Monday by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare.

Pages